Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Airlift Bioreactors Market Expected To Reach $6.71 Billion By 2030 At 9% CAGR
The airlift bioreactors market has experienced robust expansion in recent times. This market is projected to expand from $4.32 billion in 2025 to $4.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. Historically, this growth has been driven by factors such as the expansion of biopharmaceutical manufacturing capacity, the increased use of microbial fermentation processes, growth in enzyme and biofuel production, the rising adoption of disposable bioprocessing systems, and advancements in large-scale cell culture techniques.
The airlift bioreactors market is poised for significant expansion in the upcoming years, with its value expected to reach $6.71 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This projected growth throughout the forecast period stems from factors such as increasing demand for biologics and vaccines, rising investments in sustainable bio-manufacturing, the expansion of contract manufacturing services, a growing emphasis on process intensification, and the increasing adoption of smart bioreactor control systems. Prominent trends anticipated during this period include the increasing adoption of single-use airlift bioreactor systems, a rising demand for large-scale aerobic fermentation solutions, the growing integration of advanced process monitoring sensors, the expansion of modular and scalable bioreactor designs, and an enhanced focus on energy-efficient mixing mechanisms.
Download A Free Sample Report For Comprehensive Market Insights:
Airlift Bioreactors Market Industry Drivers: What Is Driving Revenue Growth?
The growing requirement for biopharmaceutical products is anticipated to boost the expansion of the airlift bioreactors market moving forward. Biopharmaceutical products are medicinal substances derived from living organisms or created using biotechnological methods, including recombinant DNA technology, cell cultures, and monoclonal antibodies. The need for biopharmaceutical products is escalating due to advancements in cell culture technologies, an increase in chronic diseases, the occurrence of age-related conditions, innovations in bioprocessing, and progress in genomics. Airlift bioreactors offer significant advantages in developing biopharmaceutical products due to their distinctive design and operational benefits, finding application in the production of therapeutic proteins, monoclonal antibodies, and vaccines. For instance, in August 2023, a report from the Alliance for Regenerative Medicine, a US-based non-profit organization, stated that there were 2,760 cell, gene, and tissue-engineering therapeutic developers worldwide in the first quarter of 2023, representing a 101% rise from 1,369 in the first quarter 2022. Thus, the increasing demand for biopharmaceutical products is propelling the growth of the airlift bioreactors market.
Airlift Bioreactors Market Segment Breakdown: Which Categories Generate The Most Revenue?
The airlift bioreactors market covered in this report is segmented –
1) By Product: Internal Airlift Loop Bioreactor, External Airlift Loop Bioreactor
2) By Capacity: 5 Liters, 7 Liters, 10 Liters, 30 Liters
3) By Usage: Single-Use Or Disposal, Reusable
4) By Production Scale: Laboratory Scale, Pilot-Scale, Large Scale
5) By End-User: Biopharmaceutical Companies, Contract Research Organizations (CROs) Or Contract Development And Manufacturing Organizations (CDMOs), Research And Development Companies
Subsegments:
1) By Internal Airlift Loop Bioreactor: Circulating Bioreactor, Non-Circulating Bioreactor
2) By External Airlift Loop Bioreactor: Single-Stage External Airlift Bioreactor, Multi-Stage External Airlift Bioreactor
Airlift Bioreactors Market Trends: What Is Shaping Future Industry Growth?
Leading companies operating in the airlift bioreactor market are concentrating on creating sophisticated cloud-connected systems aimed at boosting operational efficiency, automation, and distant oversight. These cloud-integrated solutions merge physical bioreactors with live remote surveillance, automated controls, and AI-powered optimization, allowing bioprocess teams to conduct experiments with enhanced accuracy and pace. An example is Culture Biosciences, a US company assisting biotech firms in cloud-based process development and scaling, which introduced Stratyx 250 in April 2025. This product boasts a mobile, cloud-integrated bioreactor design. The system provides cart-based portability for effortless movement within laboratories, incorporates Culture Console software for live remote monitoring and automation, and utilizes single-use bioreactor technology to minimize cleaning requirements and operational downtime. Furthermore, Stratyx 250 employs artificial intelligence and machine learning to refine bioprocesses, leading to 25% quicker development timelines, a 30% enhancement in scale-up success, and a 16% reduction in the total cost per run. Moreover, it is compatible with a Cytiva 250 mL consumable, designed to mimic large-scale reactor environments on a smaller platform, thereby facilitating efficient process development and an accelerated optimization workflow.
Airlift Bioreactors Market Key Players And Strategic Industry Positioning
Major companies operating in the airlift bioreactors market are Sartorius AG, Cytiva, Applikon Biotechnology B.V., Cellexus International Ltd, Bionet Innovación S.L., Solida Biotech GmbH, Belach Bioteknik AB, OmniBRx Biotechnologies Pvt. Ltd., Electrolab Biotech Ltd., LABOAO Instrument Equipment Co. Ltd., Bailun Biotechnology Co. Ltd., BioReactor Sciences Inc., Shree Biocare Solutions Pvt. Ltd., Lab1st Scientific Co. Ltd., Cedarstone Industry LLC, New Brunswick Scientific Co. Inc., Eppendorf AG, Kuhner AG, Thermo Fisher Scientific Inc., Lonza Group AG, ABEC Inc., Pierre Guérin SAS, Bioengineering AG
Access The Complete Airlift Bioreactors Market Report:
Airlift Bioreactors Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the airlift bioreactor market in 2025. The regions covered in the airlift bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.